$LSTA
LISATA THERAPEUTICS, INC. Stock $lsta

$lsta Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000032001715000028 Filed on May 06, 2015

Income Statement

Concept	2015 Q2	2015 Q1	2014 Q1
Revenue	$5.867M	$3.172M	$4.056K
YoY Change	130596.44%	78112.01%	60.7%
Cost Of Revenue	$5.799M	$3.369M	$3.825M
YoY Change	57.69%	-11.94%	59.92%
Gross Profit	$68.17K	-$196.3K	-$3.821M
YoY Change	-101.86%	-94.86%	-2998.88%
Gross Profit Margin	1.16%	-6.19%	-94215.68%
Selling, General & Admin	$8.736M	$11.09M	$8.970M
YoY Change	17.33%	23.61%	54.61%
% of Gross Profit	12816.13%
Research & Development	$7.601M	$6.804M	$4.759M
YoY Change	31.14%	42.96%	50.54%
% of Gross Profit	11150.18%
Depreciation & Amortization	$650.0K	$600.0K	$440.0K
YoY Change	18.18%	36.36%	-20.0%
% of Gross Profit	953.54%
Operating Expenses	$31.54M	$21.26M	$17.55M
YoY Change	86.39%	21.11%	54.59%
Operating Profit	-$25.67M	-$18.09M	-$13.50M
YoY Change	106.5%	33.99%	52.85%
Interest Expense	$547.3K	$551.0K	$94.16K
YoY Change	416.76%	485.16%	116.15%
% of Operating Profit
Other Income/Expense, Net	$4.808M	-$1.097M	-$283.7K
YoY Change	-1748.44%	286.66%	760.92%
Pretax Income	-$20.86M	-$19.18M	-$13.78M
YoY Change	63.98%	39.2%	55.48%
Income Tax	-$3.703M	$46.63K	$47.41K
% Of Pretax Income
Net Earnings	-$17.13K	-$19.19K	-$13.68K
YoY Change	35.87%	40.24%	55.46%
Net Earnings / Revenue	-0.29%	-0.6%	-337.33%
Basic Earnings Per Share
Diluted Earnings Per Share	-$3.841M	-$5.104M	-$4.868M
COMMON SHARES
Basic Shares Outstanding	40.15M shares	38.46M shares	28.58M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q2	2015 Q1	2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$39.22M	$19.13M	$41.40M
YoY Change	16.09%	-53.79%	345.16%
Cash & Equivalents	$36.21M	$19.13M	$41.36M
Short-Term Investments	$3.012M	$0.00
Other Short-Term Assets	$7.000M	$7.900M	$3.300M
YoY Change	55.56%	139.39%	32.0%
Inventory			$1.476M
Prepaid Expenses
Receivables	$1.298M	$1.969M	$1.888M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$47.47M	$29.02M	$46.56M
YoY Change	16.2%	-37.67%	267.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.81M	$15.85M	$13.79M
YoY Change	7.5%	14.95%	27.76%
Goodwill	$25.21M	$25.21M	$11.12M
YoY Change	78.89%	126.75%	0.0%
Intangibles	$37.86M	$47.41M	$13.72M
YoY Change	-23.31%	245.44%	-4.22%
Long-Term Investments
YoY Change
Other Assets	$1.271M	$1.325M	$1.205M
YoY Change	-12.9%	9.99%	23.05%
Total Long-Term Assets	$81.15M	$89.80M	$39.84M
YoY Change	-12.31%	125.4%	7.03%
TOTAL ASSETS
Total Short-Term Assets	$47.47M	$29.02M	$46.56M
Total Long-Term Assets	$81.15M	$89.80M	$39.84M
Total Assets	$128.6M	$118.8M	$86.39M
YoY Change	-3.58%	37.53%	73.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.266M	$2.929M	$3.296M
YoY Change	-58.65%	-11.15%	50.41%
Accrued Expenses	$7.178M	$5.724M	$2.382M
YoY Change	177.43%	140.33%	41.51%
Deferred Revenue
YoY Change
Short-Term Debt	$900.0K	$1.100M	$200.0K
YoY Change	350.0%	450.0%	-94.12%
Long-Term Debt Due	$1.361M	$2.243M	$800.0K
YoY Change	70.14%	180.37%	700.0%
Total Short-Term Liabilities	$16.33M	$17.46M	$8.786M
YoY Change	37.1%	98.75%	-4.79%
LONG-TERM LIABILITIES
Long-Term Debt	$13.64M	$12.76M	$3.800M
YoY Change	249.71%	235.71%	3700.0%
Other Long-Term Liabilities	$3.467M	$930.4K	$635.0K
YoY Change	446.02%	46.51%	130.62%
Total Long-Term Liabilities	$17.11M	$13.69M	$27.33M
YoY Change	2593.84%	-49.91%	134.27%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.33M	$17.46M	$8.786M
Total Long-Term Liabilities	$17.11M	$13.69M	$27.33M
Total Liabilities	$62.67M	$68.85M	$36.11M
YoY Change	11.72%	90.64%	72.85%
SHAREHOLDERS EQUITY
Retained Earnings	-$327.6M	-$310.4M	-$250.1M
YoY Change	24.71%	24.15%	21.27%
Common Stock	$55.45K	$39.42K	$28.59K
YoY Change	58.71%	37.88%	-83.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$705.7K	$705.7K	$705.7K
YoY Change	0.0%	0.0%	6.03%
Treasury Stock Shares
Shareholders Equity	$66.38M	$50.40M	$59.64M
YoY Change
Total Liabilities & Shareholders Equity	$128.6M	$118.8M	$86.39M
YoY Change	-3.58%	37.53%	73.14%

Cashflow Statement

Concept	2015 Q2	2015 Q1	2014 Q1
OPERATING ACTIVITIES
Net Income	-$17.13K	-$19.19K	-$13.68K
YoY Change	35.87%	40.24%	55.46%
Depreciation, Depletion And Amortization	$650.0K	$600.0K	$440.0K
YoY Change	18.18%	36.36%	-20.0%
Cash From Operating Activities	-$7.590M	-$14.24M	-$11.25M
YoY Change	-32.59%	26.54%	57.71%
INVESTING ACTIVITIES
Capital Expenditures	-$1.460M	$344.5K	$1.240M
YoY Change	21.67%	-72.21%	2213.95%
Acquisitions
YoY Change
Other Investing Activities	-$3.010M	$7.050M
YoY Change	245.98%
Cash From Investing Activities	-$4.470M	$6.704M	-$1.240M
YoY Change	115.94%	-640.85%	2213.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$0.00
YoY Change
Cash From Financing Activities	29.14M	$7.493M	$7.719M
YoY Change	503.31%	-2.93%	185.32%
NET CHANGE
Cash From Operating Activities	-7.590M	-$14.24M	-$11.25M
Cash From Investing Activities	-4.470M	$6.704M	-$1.240M
Cash From Financing Activities	29.14M	$7.493M	$7.719M
Net Change In Cash	17.08M	-$42.78K	-$4.774M
YoY Change	-300.94%	-99.1%	6.47%
FREE CASH FLOW
Cash From Operating Activities	-$7.590M	-$14.24M	-$11.25M
Capital Expenditures	-$1.460M	$344.5K	$1.240M
Free Cash Flow	-$6.130M	-$14.58M	-$12.49M
YoY Change	-39.07%	16.74%	73.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q1	dei	Amendment Flag AmendmentFlag	false
CY2015Q1	nbs	Sharesvestedandexpectedtovest Sharesvestedandexpectedtovest	3545756	shares
CY2014Q1	nbs	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	1275000	USD
CY2015Q1	nbs	Subsidiary Ownership Interest By Parent SubsidiaryOwnershipInterestByParent	0.966
CY2015Q1	nbs	Warrants Canceled WarrantsCanceled	5200	shares
CY2015Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2015Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015Q1	dei	Document Period End Date DocumentPeriodEndDate	2015-03-31
CY2015Q1	dei	Document Type DocumentType	10-Q
CY2015Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000320017
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40151373	shares
CY2015Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2015Q1	dei	Entity Registrant Name EntityRegistrantName	NeoStem, Inc.
CY2014Q4	nbs	Aggregate Intrinsic Value Warrants Outstanding AggregateIntrinsicValueWarrantsOutstanding	1000	USD
CY2015Q1	nbs	Aggregate Intrinsic Value Warrants Outstanding AggregateIntrinsicValueWarrantsOutstanding	0	USD
CY2015Q1	nbs	Aggregate Intrinsic Value Warrantsvested AggregateIntrinsicValueWarrantsvested	0	USD
CY2015Q1	nbs	Aggregate Intrinsic Value Warrantsvestedandexpectedtovest AggregateIntrinsicValueWarrantsvestedandexpectedtovest	0	USD
CY2014Q1	nbs	Changein Ownershipin Subsidiary ChangeinOwnershipinSubsidiary	0	USD
CY2015Q1	nbs	Changein Ownershipin Subsidiary ChangeinOwnershipinSubsidiary	0	USD
CY2014Q1	nbs	Clinical Services Reimbursement ClinicalServicesReimbursement	700000	USD
CY2015Q1	nbs	Clinical Services Reimbursement ClinicalServicesReimbursement	500000	USD
CY2014Q4	nbs	Common Stock Warrants Shares CommonStockWarrantsShares	3550956	shares
CY2015Q1	nbs	Common Stock Warrants Shares CommonStockWarrantsShares	3545756	shares
CY2014Q1	nbs	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	-1658952	USD
CY2015Q1	nbs	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	-1205775	USD
CY2011Q4	nbs	Percentageof Net Sales PercentageofNetSales	0.10
CY2011Q4	nbs	Percentageoflicensecost Percentageoflicensecost	0.30
CY2014Q4	nbs	Preferred Stock Shares Designated PreferredStockSharesDesignated	825000	shares
CY2015Q1	nbs	Preferred Stock Shares Designated PreferredStockSharesDesignated	825000	shares
CY2014Q1	nbs	Provision For Reduction Of Doubtful Accounts ProvisionForReductionOfDoubtfulAccounts	1711	USD
CY2015Q1	nbs	Provision For Reduction Of Doubtful Accounts ProvisionForReductionOfDoubtfulAccounts	1873	USD
CY2015Q1	nbs	Warrants Exercised WarrantsExercised	0	shares
CY2015Q1	nbs	Warrants Expired WarrantsExpired	0	shares
CY2015Q1	nbs	Warrants Granted WarrantsGranted	0	shares
CY2014Q1	nbs	Weighted Average Estimated Fair Value Of Restricted Stock WeightedAverageEstimatedFairValueOfRestrictedStock	7.62
CY2015Q1	nbs	Weighted Average Estimated Fair Value Of Restricted Stock WeightedAverageEstimatedFairValueOfRestrictedStock	3.61
CY2015Q1	nbs	Weighted Average Exercise Price Warrants Canceled WeightedAverageExercisePriceWarrantsCanceled	14.20
CY2015Q1	nbs	Weighted Average Exercise Price Warrants Exercisable WeightedAverageExercisePriceWarrantsExercisable	14.13
CY2015Q1	nbs	Weighted Average Exercise Price Warrants Exercised WeightedAverageExercisePriceWarrantsExercised	0.00
CY2015Q1	nbs	Weighted Average Exercise Price Warrants Expired WeightedAverageExercisePriceWarrantsExpired	0.00
CY2015Q1	nbs	Weighted Average Exercise Price Warrants Granted WeightedAverageExercisePriceWarrantsGranted	0.00
CY2014Q4	nbs	Weighted Average Exercise Price Warrants Outstanding WeightedAverageExercisePriceWarrantsOutstanding	14.12
CY2015Q1	nbs	Weighted Average Exercise Price Warrants Outstanding WeightedAverageExercisePriceWarrantsOutstanding	14.12
CY2015Q1	nbs	Weighted Average Exercise Price Warrantsvestedexpectedtovest WeightedAverageExercisePriceWarrantsvestedexpectedtovest	14.12
CY2014	nbs	Weighted Average Remaining Contractual Termwarrantoutstanding WeightedAverageRemainingContractualTermwarrantoutstanding	P2Y1M13D
CY2014Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	151300	USD
CY2015Q1	nbs	Weighted Average Remaining Contractual Termwarrantoutstanding WeightedAverageRemainingContractualTermwarrantoutstanding	P1Y10M17D
CY2015Q1	nbs	Weighted Average Remaining Contractual Termwarrantsvested WeightedAverageRemainingContractualTermwarrantsvested	P1Y10M17D
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5661173	USD
CY2015Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2928703	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3111274	USD
CY2015Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1968790	USD
CY2014Q1	us-gaap	Accretion Expense AccretionExpense	0	USD
CY2015Q1	us-gaap	Accretion Expense AccretionExpense	29724	USD
CY2014Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	18260000	USD
CY2015Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	18810000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4322901	USD
CY2015Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5723787	USD
CY2014Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	4322900	USD
CY2015Q1	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	5723800	USD
CY2014Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	495400	USD
CY2015Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	463600	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1329	USD
CY2015Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	350428903	USD
CY2015Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	361503313	USD
CY2014Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3893600	USD
CY2015Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3715700	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	385362	USD
CY2015Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	383490	USD
CY2015Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	151300	USD
CY2014Q4	us-gaap	Assets Assets	126275392	USD
CY2015Q1	us-gaap	Assets Assets	118813911	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	36281544	USD
CY2015Q1	us-gaap	Assets Current AssetsCurrent	29018262	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	7080000	USD
CY2015Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	0	USD
CY2015Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	14513100	USD
CY2015Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	0	USD
CY2015Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	0	USD
CY2015Q1	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	14513100	USD
CY2015Q1	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	14513100	USD
CY2015Q1	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	14513100	USD
CY2015Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	14513100	USD
CY2014Q2	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	33500000	USD
CY2014Q2	us-gaap	Business Combination Acquired Receivables Fair Value BusinessCombinationAcquiredReceivablesFairValue	45000	USD
CY2014Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	190000	USD
CY2015Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	550000	USD
CY2014Q2	us-gaap	Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh	90000000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	34290000	USD
CY2014Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	18260000	USD
CY2015Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	18810000	USD
CY2014Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	11900000	USD
CY2014Q4	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	12800000	USD
CY2015Q1	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	13200000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	51000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	201000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	19000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	333000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Noncurrent BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent	13901000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	2014000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	19400000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	1041000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	33491000	USD
CY2015Q1	us-gaap	Cash Cash	14513100	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46133759	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	41359652	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19174061	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19131285	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4774107	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-42776	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2015Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-19232817	USD
CY2014Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	0.01	shares
CY2015Q1	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	0.01	shares
CY2014Q1	us-gaap	Cost Of Revenue CostOfRevenue	3825444	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-13830084	USD
CY2015Q1	us-gaap	Cost Of Revenue CostOfRevenue	3368612	USD
CY2015Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	10000000	USD
CY2014Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	2566989	USD
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36783857	shares
CY2015Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39423911	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5329593	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36783857	shares
CY2015Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39423911	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	36784	USD
CY2015Q1	us-gaap	Common Stock Value CommonStockValue	39424	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13682057	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19188225	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-148027	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-44592	USD
CY2015Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	3621351	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4334120	USD
CY2015Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5505819	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	18176190	USD
CY2015Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	18222823	USD
CY2015Q1	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	0	USD
CY2014Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	444452	USD
CY2015Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	604440	USD
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.49
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.51
CY2014Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	2807200	USD
CY2015Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	3335900	USD
CY2014Q2	us-gaap	Equity Issued In Business Combination Fair Value Disclosure EquityIssuedInBusinessCombinationFairValueDisclosure	21600000	USD
CY2015Q1	us-gaap	Fair Value Estimate Not Practicable Investments FairValueEstimateNotPracticableInvestments	14513100	USD
CY2015Q1	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	550000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2498600	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2649900	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	44534400	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	453900	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	605200	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	605200	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	605200	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	605200	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	50059000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	50059000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	47560400	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	47409100	USD
CY2014Q4	us-gaap	Goodwill Goodwill	25209336	USD
CY2015Q1	us-gaap	Goodwill Goodwill	25209336	USD
CY2014Q2	us-gaap	Goodwill Goodwill	14092000	USD
CY2015Q1	us-gaap	Goodwill Gross GoodwillGross	25200000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-148027	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-44592	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13782675	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19184855	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	47409	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	46633	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	25012	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1144356	USD
CY2014Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-47409	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-46633	USD
CY2014Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	216515	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1171699	USD
CY2014Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	205589	USD
CY2015Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1054362	USD
CY2014Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	53035	USD
CY2015Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	61711	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	271149	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-52331	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	47560406	USD
CY2015Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	47409104	USD
CY2014Q1	us-gaap	Interest Expense InterestExpense	94156	USD
CY2015Q1	us-gaap	Interest Expense InterestExpense	550964	USD
CY2015Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	300000	USD
CY2014Q1	us-gaap	Interest Paid InterestPaid	93100	USD
CY2015Q1	us-gaap	Interest Paid InterestPaid	372550	USD
CY2014Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	3893616	USD
CY2015Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	3715759	USD
CY2014Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	200000	USD
CY2015Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	400000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	68201603	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16244582	USD
CY2015Q1	us-gaap	Liabilities Liabilities	68845352	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	126275392	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	118813911	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	17462851	USD
CY2015Q1	us-gaap	Long Term Debt LongTermDebt	18900000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1109612	USD
CY2015Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	2242971	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	5400000	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	5700000	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	5700000	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2100000	USD
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13890388	USD
CY2015Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	12757029	USD
CY2014Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	825897	USD
CY2015Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	662294	USD
CY2014Q4	us-gaap	Marketable Securities MarketableSecurities	7080053	USD
CY2015Q1	us-gaap	Marketable Securities MarketableSecurities	0	USD
CY2015Q1	us-gaap	Marketable Securities Restricted Current MarketableSecuritiesRestrictedCurrent	14513100	USD
CY2014Q4	us-gaap	Minority Interest MinorityInterest	-441047	USD
CY2015Q1	us-gaap	Minority Interest MinorityInterest	-435102	USD
CY2015Q1	us-gaap	Minority Interest Ownership Percentage By Noncontrolling Owners MinorityInterestOwnershipPercentageByNoncontrollingOwners	0.034
CY2015Q1	us-gaap	Mortgage Loans On Real Estate Carrying Amount Of Mortgages MortgageLoansOnRealEstateCarryingAmountOfMortgages	3100000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7719039	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7493021	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1239606	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6704470	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11253540	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14240267	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13682057	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19186896	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-283707	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1096991	USD
CY2014Q4	us-gaap	Notes Payable NotesPayable	1600000	USD
CY2015Q1	us-gaap	Notes Payable NotesPayable	1700000	USD
CY2014Q4	us-gaap	Notes Payable Current NotesPayableCurrent	816776	USD
CY2015Q1	us-gaap	Notes Payable Current NotesPayableCurrent	1061571	USD
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	17554543	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	21260143	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-13498968	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-18087864	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	8252600	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1909200	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1023800	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1841000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	2039300	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	1439300	USD
CY2014Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	177200000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	1020300	USD
CY2015Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	1924300	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1263375	USD
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1325085	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1329	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1329	USD
CY2015Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	10000	shares
CY2015Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	10000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	10000	shares
CY2015Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	10000	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	100	USD
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1239606	USD
CY2015Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	344530	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2015Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2014Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2015Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1329	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	804546	USD
CY2015Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	930355	USD
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-189551	USD
CY2015Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-546027	USD
CY2015Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	100000	USD
CY2015Q1	us-gaap	Preferred Stock Value PreferredStockValue	100	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4349167	USD
CY2015Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4296836	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	11700000	USD
CY2014Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	5630625	USD
CY2015Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	7411828	USD
CY2014Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	958014	USD
CY2015Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	340270	USD
CY2014Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2015Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	7049000	USD
CY2014Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	71360	USD
CY2015Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2014Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1275000	USD
CY2015Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2014Q1	us-gaap	Profit Loss ProfitLoss	-13830084	USD
CY2015Q1	us-gaap	Profit Loss ProfitLoss	-19231488	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15960731	USD
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15852124	USD
CY2014Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	163192	USD
CY2015Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	259077	USD
CY2014Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	52768	USD
CY2015Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4759083	USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6803632	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-291246538	USD
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-310433434	USD
CY2014Q1	us-gaap	Revenues Revenues	4055575	USD
CY2015Q1	us-gaap	Revenues Revenues	3172279	USD
CY2014Q3	us-gaap	Secured Long Term Debt SecuredLongTermDebt	20000000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	58514836	USD
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	50403661	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	62026435	USD
CY2014Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8970016	USD
CY2015Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11087899	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3545756	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	28600	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	0	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	USD
CY2014Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	329698	shares
CY2015Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	818004	shares
CY2014Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5630625	USD
CY2015Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7411828	USD
CY2014Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	2511700	USD
CY2015Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	2955800	USD
CY2014Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3893616	USD
CY2015Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3715759	USD
CY2014Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	59066952	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	58073789	USD
CY2015Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	49968559	USD
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	705742	USD
CY2015Q1	us-gaap	Treasury Stock Value TreasuryStockValue	705742	USD
CY2014Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	28120847	shares
CY2015Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	37594894	shares

Files In Submission

Name	View Source	Status
0000320017-15-000028-index-headers.html	Edgar Link	pending
0000320017-15-000028-index.html	Edgar Link	pending
0000320017-15-000028.txt	Edgar Link	pending
0000320017-15-000028-xbrl.zip	Edgar Link	pending
exh101cspa.htm	Edgar Link	pending
exh41regrights.htm	Edgar Link	pending
exh51phopinion.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
nbs-10qx20150331.htm	Edgar Link	pending
nbs-20150331.xml	Edgar Link	completed
nbs-20150331.xsd	Edgar Link	pending
nbs-20150331_cal.xml	Edgar Link	unprocessable
nbs-20150331_def.xml	Edgar Link	unprocessable
nbs-20150331_lab.xml	Edgar Link	unprocessable
nbs-20150331_pre.xml	Edgar Link	unprocessable
nbs-ex311_20150331xq1.htm	Edgar Link	pending
nbs-ex312_20150331xq1.htm	Edgar Link	pending
nbs-ex321_20150331xq1.htm	Edgar Link	pending
nbs-ex322_20150331xq1.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LSTA
LISATA THERAPEUTICS, INC. Stock $lsta

2015 Q2 Form 10-Q Financial Statement

#000032001715000028 Filed on May 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LSTA LISATA THERAPEUTICS, INC. Stock $lsta

2015 Q2 Form 10-Q Financial Statement

#000032001715000028 Filed on May 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LSTA
LISATA THERAPEUTICS, INC. Stock $lsta